Concepedia

Cytokines as predictors for sustained response and as markers for immunomodulation in patients with chronic hepatitis C

Manuela G. Neuman, Jean‐Pierre Benhamou, Izabella M. Malkiewicz, Raoudha Akremi, Neil H. Shear, Tarik Asselah, Asma Ibrahim, Nathalie Boyer, Michelle Martinot-Peignoux, Pearl Jacobson-Brown,

Clinical Biochemistry · 2001 · 65 citations · 25 references

DOI

Concepts

References

25

Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

Thierry Poynard, Patrick Marcellin, Samuel S. Lee et al. · The Lancet · 1998 · 2.3K citations

, , +17

Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy

Avidan U. Neumann, Nancy P. Lam, Harel Dahari et al. · Science · 1998 · 2.1K citations

, , +17

EASL International Consensus Conference on Hepatitis C Paris, 26–28 February 1999

Journal of Hepatology · 1999 · 707 citations

, , +14

Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: Role of membrane oxidative damage

Lucia De Franceschi, Giovanna Fattovich, Franco Turrini et al. · Hepatology · 2000 · 447 citations · Full text

, , +10

Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa

Catherine Edwards-Smith, Julie R. Jonsson, David M. Purdie et al. · Hepatology · 1999 · 406 citations · Full text

, , +17